Overview

Pre-op Rectal ChemoRad +/- Cetuximab

Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to find out what effects (good and bad) cetuximab has on rectal cancer.
Phase:
Phase 2
Details
Lead Sponsor:
US Oncology Research
Collaborators:
Bristol-Myers Squibb
Eli Lilly and Company
ImClone LLC
Treatments:
Cetuximab
Fluorouracil